Treatment of low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
Treatment of severe aplastic anaemia.
Mechanism of action:
Eltromag 25mg tablet stimulates megakaryocytes, the large bone marrow cells responsible for producing platelets.
By raising the number of platelets in the blood, this drug prevents bleeding and bruising.
Important safety information:
Pregnancy: not recommended for pregnant patients as it may cause fetal harm.
Breastfeeding: it is not known whether Eltromag 25mg tablet passes into breast milk.
Lungs: it is unknown whether Eltromag 25mg tablet can be prescribed for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.
Liver: cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure.
Alcohol: it is unknown whether alcohol may interact with the Eltromag 25mg tablet.
Driving: driving vehicles or operating heavy machinery is unsafe after taking the Eltromag 25mg tablet. It may cause dizziness and impair concentration.
Contraindications:
Known hypersensitivity or allergic reactions to the drug or its components.
Severe liver impairment or active liver disease.
Children under one with ITP.
Patients under 18 with low platelet counts caused by hepatitis C or severe aplastic anaemia.
Side effects:
Nausea
Diarrhea, abdominal pain
Common cold
Cough
Respiratory tract infection
Back pain
High temperature, cough
Loss of appetite
Hair loss
Swelling in feet or hands
Headache, dizziness
Mouth and throat pain
Joint pain
Administration instructions:
It is an orally available prescription drug.
Your doctor will decide the dose and duration of the drug based on the disease condition and other factors.
Always take an Eltromag 25mg tablet as prescribed by your doctor.
Take the tablet with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.
Do not take more than one dose of this drug daily.
Do not take dairy products, antacids, and supplements containing iron, aluminum, magnesium, calcium, selenium, zinc, or calcium within 2 hours after or 4 hours before taking the medication.
Monitoring:
Regular monitoring of white blood cell count, platelet count, blood clotting factors, heart rate, eye tests, and complete blood count.
FAQs:
What is ITP?
Immune thrombocytopenia, also known as ITP, is a rare blood disorder. People with ITP have insufficient platelets in their blood. A low platelet count can cause bruising and bleeding.
Who should not use the Eltromag 25mg tablet?
People with immune (primary thrombocytopenia (ITP) and children under one should not use Eltromag 25mg tablets. It is also not suggested for people with severe aplastic anemia and hepatitis C.
Will you be monitored during treatment with the Eltromag 25mg tablet?
Yes, you will be monitored during the Eltromag 25mg tablet treatment. Your healthcare provider will regularly access your white blood cell, platelets, blood clotting factors, heart rate, eye test, and complete blood count.
Is it safe to take a Eltromag 25mg tablet on an empty stomach?
Yes, Eltromag 25mg tablets should be taken on an empty stomach. Because antacids, mineral and vitamin supplements (iron, calcium, magnesium, aluminum, selenium, and zinc), dairy products, calcium-enriched foods, and fortified juices interfere with this drug absorption. So, please take them at least two hours before or four hours after taking the medication.
What happens if you discontinue using the Eltromag 25mg tablet?
If you discontinue using Eltromag 25mg tablets suddenly, it decreases platelet count as it can lead to severe bleeding. However, telling your healthcare practitioner before discontinuing this medication is advisable.
How to store a Eltromag 25mg tablet?
Store Eltromag 25mg tablet at 25°C and out of the reach of children. After the expiration date, do not use this medication.